- Vaccine Name: Adacel-Polio
- Target Pathogen: Poliovirus
- Target Disease: Polio
- Product Name: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine
- Tradename: Adacel-Polio
- Manufacturer: Sanofi Pasteur SA
- Type: Toxoid vaccine + Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Preservative: 2-phenoxyethanol
- Allergen: Neomycin, Polymyxin B, Streptomycin
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store at 2° to 8°C (35° to 46°F), do not freeze.
- Approved Age for Licensed Use: 4 years and older
- Description: ADACEL®-POLIO is a sterile, uniform, cloudy, white suspension of tetanus and diphtheria toxoids and acellular pertussis vaccine adsorbed separately on aluminum phosphate and combined with inactivated poliomyelitis vaccine (vero cell origin) types 1, 2 and 3, and suspended in water for injection. Acellular pertussis vaccine is composed of five purified pertussis antigens (PT, FHA, PRN and FIM). (Product Monograph: Adacel-Polio)
|
